StonvexLoading…
StonvexStonvexStonvexCore line items from ENTA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $65.32M | $67.64M | $79.20M | $86.16M |
Operating Income | $-85.35M | $-121.69M | $-137.21M | $-123.84M |
Net Income | $-81.89M | $-116.05M | $-133.82M | $-121.75M |
EPS (Diluted) | $-3.84 | $-5.48 | $-6.38 | $-5.91 |
Total Assets | $280.73M | $376.65M | $462.27M | $375.41M |
Total Liabilities | $216.01M | $247.84M | $245.54M | $54.08M |
Cash & Equivalents | $32.30M | $37.23M | $85.39M | $43.99M |
Free Cash Flow OCF − CapEx | $-32.17M | $-96.71M | $-112.21M | $-86.91M |
Shares Outstanding | 21.39M | 21.19M | 21.06M | 20.79M |